Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report

Fuente: Redalyc
Saved in:
Bibliographic Details
Main Author: Laura González-Fernández
Format: Artículo científico
Language:en
Published: Sociedad Latinoamericana de Hipertensión 2021
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1876460364115214336
author Laura González-Fernández
author_facet Laura González-Fernández
contents Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report Laura González-Fernández Roberto José Añez-Ramos Alejandra Maricel Rivas-Montenegro Diego Muñoz Moreno Juan Carlos Percovich-Hualpa Medicina Raynaud vasospasm cabergoline case report adverse effects Digital vasospasm is a known adverse effect of dopamine agonists such as bromocriptine; however, it has rarely been reported with cabergoline. We describe a case of Raynaud's phenomenon as a side effect of treatment with the latter in a 52-year-old woman with a macroprolactinoma, forcing discontinuation. In this context, we conducted a review of the literature, with emphasis on the possible criteria for discontinuation of treatment with dopaminergic agonists in patients with macroprolactinoma. 2021 otro 1856-4550 https://www.redalyc.org/articulo.oa?id=170269310013 https://www.redalyc.org/journal/1702/170269310013/ https://www.redalyc.org/journal/1702/170269310013/html/ https://www.redalyc.org/journal/1702/170269310013/170269310013.epub https://www.redalyc.org/journal/1702/170269310013/movil https://doi.org/10.5281/zenodo.5514223 en http://www.redalyc.org/revista.oa?id=1702 Revista Latinoamericana de Hipertensión application/pdf Sociedad Latinoamericana de Hipertensión Revista Latinoamericana de Hipertensión (República Bolivariana de Venezuela) Num.2 Vol.16
format Artículo científico
id redalyc_170269310013
institution Redalyc
language en
publishDate 2021
publisher Sociedad Latinoamericana de Hipertensión
spellingShingle Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report
Laura González-Fernández
Medicina
Raynaud
vasospasm
cabergoline
case report
adverse effects
Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report Laura González-Fernández Roberto José Añez-Ramos Alejandra Maricel Rivas-Montenegro Diego Muñoz Moreno Juan Carlos Percovich-Hualpa Medicina Raynaud vasospasm cabergoline case report adverse effects Digital vasospasm is a known adverse effect of dopamine agonists such as bromocriptine; however, it has rarely been reported with cabergoline. We describe a case of Raynaud's phenomenon as a side effect of treatment with the latter in a 52-year-old woman with a macroprolactinoma, forcing discontinuation. In this context, we conducted a review of the literature, with emphasis on the possible criteria for discontinuation of treatment with dopaminergic agonists in patients with macroprolactinoma. 2021 otro 1856-4550 https://www.redalyc.org/articulo.oa?id=170269310013 https://www.redalyc.org/journal/1702/170269310013/ https://www.redalyc.org/journal/1702/170269310013/html/ https://www.redalyc.org/journal/1702/170269310013/170269310013.epub https://www.redalyc.org/journal/1702/170269310013/movil https://doi.org/10.5281/zenodo.5514223 en http://www.redalyc.org/revista.oa?id=1702 Revista Latinoamericana de Hipertensión application/pdf Sociedad Latinoamericana de Hipertensión Revista Latinoamericana de Hipertensión (República Bolivariana de Venezuela) Num.2 Vol.16
title Raynaud’s phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report
topic Medicina
Raynaud
vasospasm
cabergoline
case report
adverse effects
url https://www.redalyc.org/articulo.oa?id=170269310013
https://www.redalyc.org/journal/1702/170269310013/
https://www.redalyc.org/journal/1702/170269310013/html/
https://www.redalyc.org/journal/1702/170269310013/170269310013.epub
https://www.redalyc.org/journal/1702/170269310013/movil
https://doi.org/10.5281/zenodo.5514223